Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 7/25/16 → 9/6/16 |
Financiación
- Chimerix Incorporated: 6.052,00 US$
A Randomized, Double Blind, Multicenter, Phase 3 Study of Efficacy, Safety, and Tolerability of Brincidofovir vs Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV-Seropositive Kidney Transplant Recipients who Recieved Antilymphocyte Indu
- Shah, Malay (PI)